FGFR Inhibitors

Innovative process design and industrialization of key intermediates for FGFR kinase inhibitors multПодробнее

Impact of #FGFR Inhibitors in #bladdercancer #cancer #uc #news #cancerresearchПодробнее

Her-2/neu и FGFR. Место молодежи – FGFR ингибиторы в онкологииПодробнее

discovery of KIN-3248, a pan-FGFR inhibitorПодробнее

Current developments in FGFR inhibitors for urothelial cancerПодробнее

What are FGFR Inhibitors?Подробнее

Новый класс препаратов в онкологии – ингибиторы FGFRПодробнее

Molecular Testing and Treatment Sequencing for Advanced UC: Navigating FGFR-Targeted TherapyПодробнее

Phase II Study of Erdafitinib in Tumors with FGFR Amplifications and Mutations or FusionsПодробнее

New FDA-Approved Therapy for Targeting FGFR Alterations In Advanced Urothelial CancerПодробнее

AACR 2023 highlights in PI3Kα and FGFR inhibitionПодробнее

Webinar: Targeting the FGFR pathway: Infigratinib in cholangiocarcinomaПодробнее

Day 3 - acquired resistance to FGFR inhibitorsПодробнее

AC22 - Explore Signaling Pathways and Combination Therapy in FGFR2-activated CholangiocarcinomaПодробнее

Advances in FGFR inhibition for hepatobiliary cancerПодробнее

Fibroblast Growth Factor Receptor | FGFR | Mutations In FGFR |Подробнее

Expansion cohort results of RAGNAR: erdafitinib in CCA with FGFR alterationsПодробнее

CCF Webinar: ASCO Recap and HighlightsПодробнее

Webinar: Targeted Treatment Strategies for Advanced Cholangiocarcinoma -Results of Promising TrialsПодробнее

Webinar: First-in Human-Studies of FGFR Inhibitor KIN-3248 and RAF Inhibitor KIN-2787Подробнее